Pharmacodynamic and Pharmacokinetic Activity of CX-801, a Masked IFNα2b PROBODY® Cytokine, in Patients with Advanced Melanoma

Benjamin Povinelli, Shannon Tsai, Kakali Dhar, Cathrine Leonowens, Stuart Johnston, Olga Vasiljeva, Madan Paidhungat, Yu-Waye Chu, Marcia Belvin, John M. Kirkwood, Yana G. Najjar, Monika Vainorius, Dylan Daniel; Poster presented at the Society for Immunotherapy of Cancer 2025 Annual Meeting, November 5-9, National Harbor, MD